Recruiting NA INTERVENTIONAL 2-arm NCT06172335

Effects of Cetoleic Acid on Atherosclerosis (Ketolinsyre's Effekt på Aterosklerose)

Effects of Ketolic Acid on Atherosclerosis Markers in High-risk Patients With Metabolic Syndrome (Effekt av Ketolinsyre på aterosklerosemarkører i høyrisikopasienter Med Metabolsk Syndrom)

Sponsor: Oslo University Hospital

Conditions Metabolic Syndrome

Interventions Cetoleic acid Control oil

Updated 5 times since 2024 Last updated: Jan 14, 2025 Started: Jan 3, 2024 Primary completion: Dec 30, 2024 Completion: Dec 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Metabolic Syndrome and is currently actively recruiting participants. Oslo University Hospital leads this study, which shows 5 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Feb 2025 — Present [monthly]

Recruiting NA
Sep 2024 — Feb 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Feb 2024 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2024 — Feb 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oslo University Hospital
University of Oslo

Data source: Oslo University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway